These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 25912112)

  • 1. Simvastatin-ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: A population-based dynamic cohort study.
    Chang SH; Wu LS; Lee CH; Kuo CT; Liu JR; Wen MS; Chen WJ; See LC; Yeh YH
    Int J Cardiol; 2015; 190():20-5. PubMed ID: 25912112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of statin plus ezetimibe versus high-intensity statin therapy in patients with acute myocardial infarction propensity-score matching analysis.
    Ji MS; Jeong MH; Ahn YK; Kim SH; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
    Int J Cardiol; 2016 Dec; 225():50-59. PubMed ID: 27710803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of ezetimibe coadministered with statins on cardiovascular events following acute coronary syndrome: a 3-year population-based retrospective cohort study in Taiwan.
    Lin CF; Gau CS; Wu FL; Hsiao FY; Bai CH; Shen LJ
    Clin Ther; 2011 Sep; 33(9):1120-31. PubMed ID: 21872930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of a combination of ezetimibe and statins in patients with acute coronary syndrome and multiple comorbidities: A 6-year population-based cohort study.
    Lin Wu FL; Wang J; Ho W; Chou CH; Wu YJ; Choo DW; Wang YW; Chen PY; Chien KL; Lin ZF
    Int J Cardiol; 2017 Apr; 233():43-51. PubMed ID: 28190615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-potency statin and ezetimibe use and mortality in survivors of an acute myocardial infarction: a population-based study.
    Pauriah M; Elder DH; Ogston S; Noman AY; Majeed A; Wyatt JC; Choy AM; Macdonald TM; Struthers AD; Lang CC
    Heart; 2014 Jun; 100(11):867-72. PubMed ID: 24553389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study.
    Lee YH; Hong N; Lee CJ; Park SH; Lee BW; Cha BS; Kang ES
    Sci Rep; 2018 Aug; 8(1):11925. PubMed ID: 30093717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezetimibe-Simvastatin Therapy Reduce Recurrent Ischemic Stroke Risks in Type 2 Diabetic Patients.
    Liu CH; Chen TH; Lin MS; Hung MJ; Chung CM; Cherng WJ; Lee TH; Lin YS
    J Clin Endocrinol Metab; 2016 Aug; 101(8):2994-3001. PubMed ID: 27270238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis.
    Ambegaonkar BM; Tipping D; Polis AB; Tomassini JE; Tershakovec AM
    Atherosclerosis; 2014 Dec; 237(2):829-37. PubMed ID: 25463129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Low persistence of simvastatin and ezetimibe fixed combination in the lipid lowering therapy].
    Simonyi G; Ferenci T
    Orv Hetil; 2015 Jan; 156(4):141-5. PubMed ID: 25597318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?].
    Lancellotti P; Pierard LA; Scheen AJ
    Rev Med Liege; 2015 Sep; 70(9):450-5. PubMed ID: 26638446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy analysis of ezetimibe and statins in Chinese patients with acute coronary syndrome and type 2 diabetes.
    Li L; Zhang M; Su F; Li Y; Shen Y; Shen J; Zhang D
    Lipids Health Dis; 2015 Feb; 14():10. PubMed ID: 25879728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and new-onset diabetes: a retrospective longitudinal cohort study.
    Ma T; Tien L; Fang CL; Liou YS; Jong GP
    Clin Ther; 2012 Sep; 34(9):1977-83. PubMed ID: 22939164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.
    McCormack T; Harvey P; Gaunt R; Allgar V; Chipperfield R; Robinson P;
    Int J Clin Pract; 2010 Jul; 64(8):1052-61. PubMed ID: 20487050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome.
    Jimenez JG; Rosen JB; Pirags V; Massaad R; Hanson ME; Brudi P; Triscari J
    Diabetes Obes Metab; 2013 Jun; 15(6):513-22. PubMed ID: 23279632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dual inhibition of cholesterol using the drug combination ezetimibe/simvastatin?].
    Vaverková H
    Vnitr Lek; 2007 Apr; 53(4):421-7. PubMed ID: 17578178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks.
    Kao YC; Chen TH; Liu CH; Hwang JS; Hsiao CC; Lin YS; Mao CT; Hung MJ; Li YR
    Sci Rep; 2021 Mar; 11(1):6697. PubMed ID: 33758291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
    Giugliano RP; Cannon CP; Blazing MA; Nicolau JC; Corbalán R; Špinar J; Park JG; White JA; Bohula EA; Braunwald E;
    Circulation; 2018 Apr; 137(15):1571-1582. PubMed ID: 29263150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.
    Brudi P; Reckless JP; Henry DP; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO
    Cardiology; 2009; 113(2):89-97. PubMed ID: 19018143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of statin monotherapy versus statin plus ezetimibe combination on serum uric acid levels.
    Moutzouri E; Liberopoulos EN; Florentin M; Liamis G; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):13-8. PubMed ID: 22539817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
    Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.